Jeremy Liang

Mr. Jeremy Liang

National University of Singapore, Singapore, Central Singapore, Singapore
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
YOYi-Hsuan Ou
Yi-Hsuan Ou
JLJeremy Liang
Jeremy Liang
BCBertrand Czarny
Bertrand Czarny
MWMatthias G. Wacker
Matthias G. Wacker
VYVictor Yu
Victor Yu
GPGiorgia Pastorin
Giorgia Pastorin

20 August 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YOYi-Hsuan Ou
Yi-Hsuan Ou
JLJeremy Liang
Jeremy Liang
WCWei Heng Chng
Wei Heng Chng
RMRam Pravin Kumar Muthuramalingam
Ram Pravin Kumar Muthuramalingam
ZNZi Xiu Ng
Zi Xiu Ng
GPGiorgia Pastorin
Giorgia Pastorin
In drug delivery, the development of nanovesicles that combine both synthetic and cellular components provides added biocompatibility and targeting specificity in comparison to conventional synthetic carriers such as liposomes. Produced through the fusion of U937 monocytes’ membranes and synthetic lipids, our nano-cell vesicle technology systems (nCVTs) showed promising results as targeted cancer treatment. However, no investigation has been conducted yet on the immunogenic profile and the uptake mechanisms of nCVTs. Hence, this study was aimed at exploring the potential cytotoxicity and immune cells’ activation by nCVTs, as well as the routes through which cells internalize these biohybrid systems. The endocytic pathways were selectively inhibited to establish if the presence of cellular components in nCVTs affected the internalization route in comparison to both liposomes (made up of synthetic lipids only) and nano-cellular membranes (made up of biological material only). As a result, nCVTs showed an 8-to-40-fold higher cellular internalization than liposomes within the first hour, mainly through receptor-mediated processes (i.e., clathrin- and caveolae-mediated endocytosis), and low immunostimulatory potential (as indicated by the level of IL-1α, IL-6, and TNF-α cytokines) both in vitro and in vivo. These data confirmed that nCVTs preserved surface cues from their parent U937 cells and can be rationally engineered to incorporate ligands that enhance the selective uptake and delivery toward target cells and tissues.